A Study of GC101 TIL in Advanced Melanoma (10hospital)

This study is testing a special type of cancer-fighting immune cell therapy called TIL (tumor-infiltrating lymphocytes) — cells taken from your own tumor, grown in a lab, and put back into your body to fight advanced melanoma (a type of skin cancer). **You may be eligible if...** - You have been diagnosed with melanoma (primary, relapsed, or metastatic) confirmed by biopsy - You are between 18 and 75 years old - You are reasonably active and able to care for yourself - Standard treatments have not worked or are not available for you - You have tumor tissue that can be biopsied or removed to grow the TIL cells - Your blood counts and organ function meet required minimums - Your expected survival is at least 3 months **You may NOT be eligible if...** - You have severe heart, lung, or kidney disease - You are pregnant or breastfeeding - You have an active serious infection - You are unable to meet the blood count or organ function requirements Talk to your doctor to see if this trial is right for you.